We are live on
!
Find out more
Teva Pharmaceuticals
TEVA
TEVA
795 hedge funds and large institutions have $26B invested in Teva Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 268 increasing their positions, 324 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
4% less call options, than puts
Call options by funds: $595M | Put options by funds: $620M
8% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 75
2% less funds holding
Funds holding: 812 → 795 (-17)
2.34% less ownership
Funds ownership: 58.38% → 56.04% (-2.3%)
13% less capital invested
Capital invested by funds: $30B → $26B (-$3.92B)
15% less funds holding in top 10
Funds holding in top 10: 41 → 35 (-6)
17% less repeat investments, than reductions
Existing positions increased: 268 | Existing positions reduced: 324
Holders
795
Holders Change
-17
Holders Change %
-2.09%
% of All Funds
21.21%
Holding in Top 10
35
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-14.63%
% of All Funds
0.93%
New
69
Increased
268
Reduced
324
Closed
75
Calls
$595M
Puts
$620M
Net Calls
-$24.3M
Net Calls Change
-$252M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$310M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$295M |
| 3 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$202M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$188M |
| 5 |
JP Morgan Chase
New York
|
+$179M |
